AUG 10, 2026 · JOURNAL ARTICLE
Oral nano-delivery of a gut microbial metabolite enhances T cell stemness for cancer immunotherapy
Nature Nanotechnology
A mechanistic study with in vitro screening and murine tumour models showing enhanced anti-tumour efficacy in combination with anti-PD-1, but no clinical data or human trials reported.
Reported
Compound identified3,4-dihydroxybenzoic acid
Target cell populationCD8+ T cells
Mechanism: glycolysis suppression…Akt-mTORC1-Myc pathway regulation